【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 18
1.2 List of Figures 26
2 Introduction 31
2.1 Catalyst 32
3 Clinical Outcomes 34
3.1 Disease Management 34
3.1.1 Intracranial Aneurysms 34
3.1.2 Intracranial Arteriovenous Malformations 35
3.1.3 Dural Arteriovenous Fistulas 36
3.1.4 Intracranial and Extracranial Atherosclerotic Disease 36
3.1.5 Stroke 37
3.2 Treatment Modalities 38
3.2.1 Overview 38
3.2.2 Medical/Chemical Therapy 39
3.2.3 Surgical Therapy 40
3.2.4 Endovascular Therapy 42
4 Industry Overview 53
4.1 Overview 53
4.2 Procedure Trends 53
4.2.1 Intracranial Aneurysms 53
4.2.2 Intracranial Arteriovenous Malformations 59
4.2.3 Atherosclerotic Disease 60
4.2.4 Acute Ischemic Stroke 65
4.3 Market Access 68
4.3.1 Regulatory Process 70
4.3.2 Physician Perception and Decision Making Process 76
4.3.3 Variations in Clinical Practice 82
4.3.4 Lack of Clinical Data 82
4.3.5 Regional-Level Control 83
4.3.6 Cost-Considerations 84
4.3.7 Reimbursement Trends 89
4.4 Regulatory Issues/Recalls 98
4.4.1 Regulatory Issues 98
4.4.2 Product Recalls 99
4.5 Mergers and Acquisitions/Key Partnerships 99
4.5.1 Covidien and Nfocus Neuromedical 99
4.5.2 Stryker Corporation and Surpass Medical 100
4.5.3 Covidien and MindFrame 100
4.5.4 Covidien and Reverse Medical Corporation 100
4.5.5 Stryker Corporation and Boston Scientific Neurovascular 101
4.5.6 Stryker Corporation and Concentric Medical 101
4.5.7 Covidien and ev3 102
4.5.8 Medtronic and Invatec 102
4.5.9 Johnson & Johnson and Micrus Endovascular 102
4.5.10 ev3 and Chestnut Medical Technologies 103
4.5.11 Boston Scientific Corporation and Guidant Corporation 103
4.6 Economic Impact 104
4.6.1 Economic Impact of Intracranial Aneurysms and Arteriovenous Malformations 104
4.6.2 Economic Impact of Stroke 105
4.6.3 Treatment Costs of Cerebrovascular Disease 106
5 Unmet Needs 110
5.1 Overview 110
5.2 Need for Practice, Performance, and Physician Training Guidelines 110
5.3 Lack of Clinical Data 111
5.4 Improve Management of Acute Ischemic Stroke 112
5.5 Address Complications of Surgical Therapy 114
5.6 Addressing the Challenges of Surgical Clipping 114
5.7 Lack of Optimal Treatment Strategy for Unruptured Intracranial Aneurysms 115
5.8 Need for Effective Therapies for Complex Aneurysm Morphologies and Sizes 116
5.9 Difficulty in Treating Intracranial Arteriovenous Malformations 117
5.10 Eliminating Mechanisms of Failure with Balloon Angioplasty 118
5.11 Addressing Challenges of Neurovascular Stenting 119
5.11.1 Risk of Post-Procedural Complications 119
5.11.2 In-Stent Restenosis 120
5.11.3 Stent Navigation 120
5.12 Complications of Dual Antiplatelet Therapy 120
5.13 Need to Improve Medical Therapy 121
5.14 Improve Ease of Access 122
6 Market Opportunity Analysis 123
6.1 Neurovascular Interventions Market 123
6.2 Improve Neurointerventional Device Design 123
6.3 Challenges in Treating Complex Intracranial Aneurysms and Arteriovenous Malformations 125
6.3.1 Intracranial Aneurysms 125
6.3.2 Intracranial Arteriovenous Malformations 126
6.4 Target Challenging Patient Populations 127
6.5 Optimize Care for Acute Ischemic Stroke Patients 127
6.6 Development of Drug-Eluting Devices 129
6.7 Emerging Markets 129
7 Market Drivers and Barriers 131
7.1 Market Drivers 131
7.1.1 Rising Prevalence of Disease 132
7.1.2 Improved Clinical Outcomes with Endovascular Coiling 133
7.1.3 Remodeling Techniques with Stent and Balloon-Assisted Coiling 134
7.1.4 Viable Therapeutic Option for Challenging/Complex Intracranial Aneurysms 136
7.1.5 Alternative Non-Coiling Embolization Devices for Aneurysm Treatment 137
7.1.6 Endovascular Embolization of Intracranial Arteriovenous Malformations 138
7.1.7 Imaging Assessment for Intracranial Arteriovenous Malformation Treatment 139
7.1.8 Stenting for Carotid Atherosclerotic Disease 139
7.1.9 Low-Profile Stent Systems 140
7.1.10 Improved Recanalization Rates with Mechanical Thrombectomy Devices 141
7.1.11 Cost Savings 143
7.1.12 Availability of Long-Term and Cost-Effective Data 143
7.2 Market Barriers 144
7.2.1 Complications of Neurointerventional Procedures and Devices 144
7.2.2 Lack of Clinical Data 150
7.2.3 High Cost of Treatment 150
7.2.4 Lack of Reimbursement 152
7.2.5 Lack of Superiority of Bioactive/Coated Coils 153
7.2.6 Alternative Technologies for Stroke Therapy 154
7.2.7 Regulatory Challenges: US Food and Drug Administration and European Conformity Mark 154
7.2.8 Healthcare Cost-Cutting and Reimbursement 155
7.2.9 Availability of Venture Capital 156
7.2.10 Medical Device Excise Tax 157
8 Competitive Assessment 158
8.1 Overview 158
8.2 Global Market Share 158
8.3 Marketed Products 159
8.3.1 Aachen Resonance 159
8.3.2 Abbott Vascular 161
8.3.3 Acandis 163
8.3.4 B. Braun 166
8.3.5 BALT Extrusion 167
8.3.6 Blockade Medical 172
8.3.7 Boston Scientific Corporation 173
8.3.8 Contego Medical 175
8.3.9 Cook Medical 175
8.3.10 Covidien 176
8.3.11 Gardia Medical 183
8.3.12 Gore Medical 184
8.3.13 InspireMD 186
8.3.14 ITGI Medical 187
8.3.15 Johnson & Johnson 188
8.3.16 Medikit 194
8.3.17 Medtronic 196
8.3.18 Merlin MD 199
8.3.19 MicroPort Scientific Corporation 200
8.3.20 Minvasys 202
8.3.21 Neuravi 203
8.3.22 Optimed 204
8.3.23 Penumbra 206
8.3.24 Phenox GmbH 209
8.3.25 Reverse Medical 211
8.3.26 Sequent Medical 213
8.3.27 Stryker Neurovascular Intervention 215
8.3.28 Terumo Corporation 222
8.3.29 Valor Medical 230
9 Pipeline Assessment 232
9.1 Overview 232
9.2 Pipeline by Stage of Development 232
9.3 Product Profiles 234
9.3.1 Aneurysm Occlusion Saddle 234
9.3.2 Ballstent Microcatheter 235
9.3.3 Blood Clot Removing Device 235
9.3.4 EKOS’ EkoSonic Small Vessel Endovascular System 236
9.3.5 Flow-Diverting Thin-Film Nitinol Covered Stent 236
9.3.6 Ischemic Stroke System 237
9.3.7 Janjua Aneurysm Net 238
9.3.8 Multilayer Aneurysm Repair System 238
9.3.9 NAVIMAX 239
9.3.10 Palmaz Scientific Stents 240
9.3.11 Silk Road System 241
9.3.12 Transcranial Thrombectomy Catheter 242
10 Clinical Trial Analysis 243
10.1 Overview 243
10.2 Clinical Trials to Watch 244
10.2.1 Embolization 244
10.2.2 Flow Diversion 246
10.2.3 Revascularization 249
10.2.4 Mechanical Thrombectomy 250
11 Current and Future Players 253
11.1 Overview 253
11.2 Trends in Corporate Strategy 253
11.3 Company Profiles 255
11.3.1 BALT Extrusion 255
11.3.2 Covidien 258
11.3.3 Johnson & Johnson 261
11.3.4 Penumbra 266
11.3.5 Stryker Corporation 269
11.3.6 Terumo Corporation 271
11.3.7 Abbott Vascular 275
11.3.8 Boston Scientific Corporation 277
11.3.9 Cook Medical 279
11.3.10 Gore Medical 281
11.3.11 Medtronic 283
11.3.12 Aachen Resonance 285
11.3.13 Acandis 287
11.3.14 B. Braun 290
11.3.15 Blockade Medical 291
11.3.16 Contego Medical 293
11.3.17 Gardia Medical 294
11.3.18 InspireMD 296
11.3.19 ITGI Medical 298
11.3.20 Medikit 299
11.3.21 Merlin MD 300
11.3.22 MicroPort Scientific Corporation 302
11.3.23 Minvasys 303
11.3.24 Neuravi 305
11.3.25 Optimed 306
11.3.26 Phenox GmBH 308
11.3.27 Reverse Medical 309
11.3.28 Sequent Medical 311
11.3.29 Valor Medical 312
11.3.30 Other Companies 315
12 Market Outlooks 317
12.1 By Market Segment 317
12.1.1 Embolization Device Market 319
12.1.2 Revascularization Device Market 323
12.1.3 Mechanical Thrombectomy Device Market 326
12.1.4 Access/Support Device Market 329
12.2 By Geography 331
12.2.1 Global Overview 331
12.2.2 United States 332
12.2.3 The Five European Union Markets 339
12.2.4 The Asia-Pacific Region 367
12.2.5 South America 386
13 Appendix 393
13.1 Bibliography 393
13.2 Abbreviations 417
13.3 Report Methodology 423
13.3.1 Overview 423
13.3.2 Coverage 423
13.3.3 Secondary Research 423
13.4 Physicians and Specialists Included in this Study 424
13.4.1 Vivek Gupta, MD 424
13.4.2 Zsolt Kulscár, MD, PhD 424
13.4.3 Salvatore Mangiafico, MD 424
13.4.4 Thanh Nguyen, MD, FRCPc 424
13.4.5 Eduardo Wajnberg, MD 425
13.4.6 Phil White, MD 425
13.4.7 Osama O Zaidat, MD, MS, FAAN, FAHA 425
13.5 Primary Research 425
13.5.1 Primary Research – Key Opinion Leader Interviews 425
13.5.2 Expert Panel Validation 426
13.6 Forecasting Methodology 427
13.7 About the Authors 429
13.7.1 Analysts 429
13.7.2 Global Head of Healthcare 430
13.8 About MediPoint 431
13.9 About GlobalData 431
13.10 Disclaimer 431
【レポート販売概要】
■ タイトル：世界における神経血管インターベンション市場■ 英文：MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts
■ 発行日：2014年4月2日
■ 調査会社：GlobalData
■ 商品コード：GDME0194MAR
■ 調査対象地域：グローバル
- 航空機用燃料装置の世界市場2016-2020About Aircraft Fuel Systems A fuel system consists of storage tanks, valves, pumps, filters, metering devices, fuel lines, and monitoring devices. It allows the fuel to pass to the auxiliary power unit (APU) and propulsion system. These devices are designed, developed, and certified under the Code of Federal Regulations (14 CFR) guidelines. Fuel systems largely depend on the size and complexity of …
- EMI（電磁）シールドの世界市場予測（～2024年）“EMI shielding market is expected to grow at a high rate during 2019–2024”The EMI shielding market is expected to be valued at USD 6.3 billion in 2019. It is expected to reach USD 8.2 billion by 2024 at a CAGR of 5.34% from 2019 to 2024The need for electromagnetic interference (EMI) shielding is further propelled by the increasing clock frequencies, faster slew rates, increasing packaging density, …
- LEDパッケージング装置の世界市場：ダイ・シンギュレーション、ダイ・アタッチ、基板分離、永久結合、LED検査About the Light Emitting Diode (LED) Packaging Equipment Market The numerous benefits of LED lights have aided their growth traction among end-users. They are preferred over incandescent bulbs and compact fluorescent lamps (CFLs) as they are energy efficient (they consume almost 75% less energy than other bulbs) and have a long lifespan (which is pegged at 60,000 hours, compared to 1,500 hours of …
- Hodgkin Lymphoma：グローバル臨床試験レビューH2, 2013Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hodgkin Lymphoma . It includes an overview of the trial numbers and their recruitment stat …
- 世界の水処理、排水処理装置市場Water and wastewater treatment is essential in to maintain its quality in consumption for drinking, daily public use, industrial processes, medicine, etc. There has been decline in fresh water resources in quantity as well as in quality due to increased water pollution in recent years. Various technologies are carried out for water and wastewater treatment in municipal, industrial, and other proce …
- バイオ炭の世界市場2015-2019About biochar Biochar is a porous stable solid, which is rich in carbon. It is produced from the carbonization of biomass. It is a type of charcoal used for soil amendment and filtration. Biochar’s carbon sequestration characteristics help mitigate climate change. It is naturally found in soil as a result of natural vegetation or forest fires. TechNavio's analysts forecast the global biochar marke …
- 世界の経肺薬物送達システム市場動向（2012-2016）TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. How …
- Clayton Williams Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Clayton Williams Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Clayton Williams Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- ジオテキスタイルの世界市場2016-2026Geotextiles are part of the geosynthetic group of materials which include geogrids, geomembranes, geopipes, geocomposites, geosynthetic clay liners, and geonets. A wide range of sectors have used geotextiles since 1950. The first geotextiles were woven industrial fabrics. Initially, they were used for waterfront structures, then the first nonwoven geotextiles for construction purposes were develop …
- 圧力リリーフ弁のグローバル市場動向（2014-2018）About Global Pressure Relief Valves market Pressure relief valves are the valves that release pressure from the pressurized vessel when the force exerted onto the disc is greater than the process inlet force. Industries such as Oil and Gas, Power, Chemical, Food and Beverages, Pulp and Paper, and Pharmaceutical require installation of pressure relief valves in their main production systems to cont …
- 黒鉛(グラファイト)の世界市場2018-2022About Graphite Graphite is a soft crystalline form of carbon that has a two-dimensional, planar crystalline structure. Graphite can be either natural or synthetic. Natural graphite is obtained from mining, and synthetic graphite is produced by processing coke, petroleum, and coal tar. Technavio’s analysts forecast the global graphite market to grow at a CAGR of 5.52% during the period 2018-2022. C …
- 周辺ガイドワイヤーの世界市場：用途別、地域別Global Peripheral Guidewires Market: About this market Technavio’s peripheral guidewires market analysis considers sales from both interventional and diagnostic applications. Our study also finds the sales of peripheral guidewires in Asia, Europe, North America, and ROW. In 2019, the interventional segment had a significant market share, and this trend is expected to continue over the forecast per …
- POS端末の世界市場2016-2020About the Point-of-Sale (POS) Terminals Market POS terminals allow cashless transactions to sell goods. Retailers use POS terminals to manage information about their cash flows, customers, and inventory. A POS terminal enhances the shopping experience for customers by minimizing the payment processing time and provides companies with information pertaining to the sales of their respective products …
- サイトメガロウイルスワクチンのグローバル市場機会分析（MarketVIEW: Cytomegalovirus vaccines）Cytomegalovirus (CMV) is a member of the herpesvirus family and is widely prevalent throughout the population. In the US around 50-80% of adults are infected by 40 years of age (US CDC figures) whereas in other parts of the world, especially developing countries, prevalence is much higher even at younger ages. Usually CMV infections are dormant causing no significant health issues, however, in cer …
- 燃料電池技術の世界市場展望2017-20276According to Stratistics MRC, the Global Fuel Cell Technology Market is expected to grow at a CAGR of 16.2% during the forecast period. Growing private as well as public investments is influencing the market growth. However, factors such as high catalyst cost and lack of proper fuel infrastructures are hampering the market growth. Fuel cells are used for converting chemical energy into electrical …
